| Company Name: |
Hefei fuya biotechnology co. LTD
|
| Tel: |
18096409024 |
| Email: |
sales02@foreversyn.com |
| Products Intro: |
Product Name:BRD0209/(S)-3-Cyclopropyl-4,7,7-trimethyl-4-phenyl-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b]quinolin-5-one
CAS:1597439-87-6
Purity:95% HPLC Package:100MG;500MG
|
|
| | BRD0209
(BRD 0209) Basic information |
| Product Name: | BRD0209
(BRD 0209) | | Synonyms: | BRD0209
(BRD 0209);BRD0209;5H-Pyrazolo[3,4-b]quinolin-5-one, 3-cyclopropyl-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)-;(S)-3-Cyclopropyl-4,7,7-trimethyl-4-phenyl-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b]quinolin-5-one;BRD0209/(S)-3-Cyclopropyl-4,7,7-trimethyl-4-phenyl-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b]quinolin-5-one | | CAS: | 1597439-87-6 | | MF: | C22H25N3O | | MW: | 347.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1597439-87-6.mol |  |
| | BRD0209
(BRD 0209) Chemical Properties |
| form | Solid | | color | Light yellow to yellow |
| | BRD0209
(BRD 0209) Usage And Synthesis |
| Description | BRD0209 is a highly selective and potent GSK3 inhibitor. BRD0209 demonstrates in vivo efficacy in a dopaminergic signaling paradigm modeling mood-related disorders. The mood stabilizer lithium, the first-line treatment for bipolar disorder, is hypothesized to exert its effects through direct inhibition of glycogen synthase kinase 3 (GSK3). |
| | BRD0209
(BRD 0209) Preparation Products And Raw materials |
|